[1]
Rajveer Singh Rathore et al. 2024. EVALUATION OF ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE OUTCOMES IN T2DM PATIENTS. Journal of Population Therapeutics and Clinical Pharmacology. 31, 5 (May 2024), 2249–2253. DOI:https://doi.org/10.53555/4cm8t104.